Compliance of systematic reviews articles in brain arteriovenous malformation with PRISMA statement guidelines: Review of literature

Journal of Clinical Neuroscience

Volumn 39, Issue , 2017, Pages 45-48

  Akhigbe, T ^a   Zolnourian, A ^a   Bulters, D ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Brain arteriovenous malformation; Literature review; PRISMA guidelines; Systematic reviews

Indexed keywords

BRAIN ARTERIOVENOUS MALFORMATION; CLINICAL DECISION MAKING; CLINICAL PRACTICE; FUNDING; HEALTH CARE DELIVERY; HUMAN; PATIENT CARE; POPULATION RESEARCH; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; ARTERIOVENOUS FISTULA; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LITERATURE; MEDLINE; PROTOCOL COMPLIANCE; RESEARCH; STANDARDS;

ARTERIOVENOUS FISTULA; GUIDELINE ADHERENCE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PRACTICE GUIDELINES AS TOPIC; PUBMED; RESEARCH REPORT; REVIEW LITERATURE AS TOPIC;

EID: 85013792095     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2017.02.016     Document Type: Review

References (21)

1. [1] Liberati, A., Altman, D.G., Tetzlaff, J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare intervention: explanation and elaboration. J Clin Epidemiol 62:10 (2009), e1–e34.
2. [2] Swingler, G.H., Volmink, J., Ioannidis, J.P., Number of published systematic reviews and global burden of disease: database analysis. BMJ 327 (2003), 1083–1084.
3. [3] Canadian Institutes of Health Research. Randomized controlled trials registration/application checklist; 2006. www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf [Accessed 21 September 2016].
4. [4] Moher, D., Cook, D.J., Eastwood, S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354 (1999), 1896–1900.
5. [5] Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med W64 (2009), 264–269.
6. [6] Mohr, J.P., Parides, M.K., Stapf, C., et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383 (2014), 614–621.
7. [7] Higgins, J.P.T., Green, S., Cochrane handbook for systematic reviews of interventions. The cochrane collaboration, 2011 Version 5.1.0.
8. [8] Josephson, C.B., Sauro, K., Wiebe, S., et al. Medical vs invasive therapy in AVM-related epilepsy systematic review and meta-analysis. Neurology 86:1 (2016), 64–71.
9. [9] Magro, E., Gentric, J.C., Darsaut, T.E., et al. Responses to ARUBA: a systematic review and critical analysis for the design of future arteriovenous malformation trials. J Neurosurg, 1–9, 2016.
10. [10] Busch, K.J., Kiat, H., Stephen, M., et al. Cerebral hemodynamics and the role of transcranial doppler applications in the assessment and management of cerebral arteriovenous malformations. J Clin Neurosci, 2016.
11. [11] Awad, A.J., Walcott, B.P., Stapleton, C.J., et al. Repeat radiosurgery for cerebral arteriovenous malformations. J Clin Neurosci 22:6 (2015), 945–950.
12. [12] Josephson, C.B., White, P.M., Krishan, A., et al. Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage. 2014, The Cochrane Library.
13. [13] Xu, F., Zhong, J., Ray, A., et al. Stereotactic radiosurgery with and without embolization for intracranial arteriovenous malformations: a systematic review and meta-analysis. Neurosurg Focus, 37(3), 2014, E16.
14. [14] Klimo, P. Jr, Thompson, C.J., Ragel, B.T., et al. Methodology and reporting of meta-analyses in the neurosurgical literature: a review. J Neurosurg 120:4 (2014), 796–810.
15. [15] Sackett, D.L., Rosenberg, W.M., Gray, J.A., et al. Evidence based medicine: what it is and what it isn't. BMJ 312:7023 (1996), 71–72.
16. [16] van Beijnum, J., van der Worp, H.B., Buis, D.R., et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 306:18 (2011), 2011–2019.
17. [17] Fleming, P.S., Seehra, J., Polychronopoulou, A., et al. PRISMA assessment of the reporting quality of systematic review in orthodontics. Angle Orthod 83:1 (2013), 158–163.
18. [18] Moher, D., Tetzlaff, J., Tricco, A.C., et al. Epidemiology and reporting characteristics of systematic reviews. PLoS Med, 4, 2007, e78.
19. [19] Lee, J.S., In search of the highest quality: levels of evidence in oral and maxillofacial surgery. J Oral Maxillofac Surg, 72, 2014, 2102.
20. [20] Shea, B.J., Hamel, C., Wells, G.A., et al. AMSTAR is a reliable and valid assessment tool to assess methodological quality of systematic reviews. J Clin Epidemiol 62:10 (2009), 1013–1020.
21. [21] Knobloch, K., Yoon, U., Vogt, P.M., Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 39:2 (2011), 91–92.